26.
|
Is sigmoidoscopy a viable alternative to colonoscopy for assessing endoscopic and histologic activity in ulcerative colitis?
Published online August 5, 2024 |
25.
|
Effectiveness and safety of mirikizumab as induction and maintenance therapy in patients with moderately to severely active ulcerative colitis?
Published online May 8, 2024 |
24.
|
How effective is transabdominal ultrasonography in predicting the relapse of Crohn’s Disease?
Published online February 6, 2024 |
23.
|
Comparative outcomes of acute colonic diverticulitis in immunocompromised versus immunocompetent patients: a systematic review and meta-analysis
Published online October 27, 2023 |
22.
|
Does CVC placement increase the risk of venous thromboembolism in hospitalized IBD patients without pharmacological prophylactic antithrombotic therapy?
Published online August 3, 2023 |
21.
|
Concomitant ankylosing spondylitis with inflammatory bowel disease: Clinical significance in terms of clinical outcomes
Published online May 9, 2023 |
20.
|
Are the incidence rates of hospitalized infections, herpes zoster, and malignancies different depending on treatment drugs in patients with ulcerative colitis?
Published online February 3, 2023 |
19.
|
Can educational training decrease excessive and inappropriate steroid use in patients with inflammatory bowel disease?
Published online November 3, 2022 |
18.
|
Is bile acid metabolism related to dysbiosis in patients with Crohn’s disease?
Published online August 1, 2022 |
17.
|
Is fecal microbiota transplantation effective in corticosteroid-dependent ulcerative colitis?
Published online April 29, 2022 |
16.
|
Are thiopurines safe and effective for patients with NUDT15 heterozygosity?
Published online February 7, 2022 |
15.
|
How often is immunoglobulin A nephropathy associated in patients with inflammatory bowel diseases?
Published online November 2, 2021 |
14.
|
Could the geographic area influence the demographic profile of IBD patients in India?
Published online April 29, 2021 |
13.
|
Could melatonin ameliorate the intestinal inflammation by modulating intestinal microbial composition?
Published online August 10, 2020 |
12.
|
What are the risk factors for impaired ovarian reserve in young women of reproductive age with Crohn's disease?
Published online April 22, 2020 |
11.
|
Who should continue the budesonide 2-mg foam treatment for up to week 6 in patients with mild-to-moderate distal ulcerative colitis?
Published online February 18, 2020 |
10.
|
How common is family history of inflammatory bowel disease and how does it relate to the prognosis in patients with inflammatory bowel disease in Asia?
Published online October 13, 2019 |
9.
|
Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
Published online August 2, 2019 |
8.
|
Influence of anti-tumor necrosis factor-alpha therapy on pregnant women with inflammatory bowel disease and their children’s immunity
Published online April 23, 2019 |
7.
|
Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis
Published online February 7, 2019 |
6.
|
Fecal immunochemical test and fecal calprotectin in ulcerative colitis
Published online November 1, 2018 |
5.
|
Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease
Published online August 9, 2018 |
4.
|
Comparison of efficacy of once daily multimatrix mesalazine 2.4 g/day and 4.8 g/day with other 5-aminosalicylic acid preparation in active ulcerative colitis: a randomized, double-blind study
Published online May 8, 2018 |
3.
|
Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment
Published online February 5, 2018 |
2.
|
Efficacy and safety of ustekinumab in Japanese patients with moderately to severely active Crohn's disease
Published online November 2, 2017 |
1.
|
Long-term safety and efficacy of adalimumab for intestinal Behçet's disease
Published online September 1, 2017 |